The FDA recently approved a drug treatment for HBV infection for pediatric patients 12 and older with compensated liver disease.
Tim Smith
Advertisement
Articles by Tim Smith
New research suggests the sleep quality of caregivers and patients with atopic dermatitis (inadequately-controlled with topical therapies) may improve with dupilumab treatment.
A recent study in Finland finds 2 major contributing factors to allergic disease in infants with familial risk.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves Nuzolvence (zoliflodacin) for treatment of uncomplicated urogenital gonorrhea in 12 years and up
2
Edward Hook, MD, reacts to the FDA approval of zoliflodacin for uncomplicated urogenital gonorrhea
3
Full case: A slender teen with a growing abdomen and shrinking height velocity
4
Reports: FDA launching safety review of nirsevimab and clesrovimab for RSV
5
